Prescription drug · NDA
Giapreza (Angiotensin ii) NDC 68547-501
Angiotensin ii 2.5 mg/mL · Injection · Intravenous · La Jolla Pharmaceutical Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68547-501-02 | 68547050102 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68547-501-02) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Feb 5, 2018 | |
| 68547-501-07 | 68547050107 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68547-501-07) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Aug 10, 2026 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Giapreza
- Generic name (nonproprietary)
- angiotensin ii
- Active ingredients
- Angiotensin ii — 2.5 mg/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- La Jolla Pharmaceutical CompanyNDC labeler code 68547
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 209360
- Marketing start
- Listing expires
- Other FDA classes
- Vasoconstriction (Physiologic effect)
- Identifiers
- Product ID 68547-501_2c555078-770d-43d9-93e5-40e4cf5a4acfSPL ID 2c555078-770d-43d9-93e5-40e4cf5a4acfSPL set ID c265d69a-3efe-4107-9a9e-e6fd3d531c48RxCUI 1999007, 1999012, 2611704, 2611707UNII M089EFU921UPC 0368547501023
- Pharmacologic class
- Vasoconstrictor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N468547050102followed by a unit qualifier and the quantityPackage 68547-0501-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
1. INDICATIONS AND USAGE GIAPREZA increases blood pressure in adults with septic or other distributive shock [see Clinical Studies (14)] . GIAPREZA is a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 68547-501
- What is NDC 68547-501?
- 68547-501 is the product NDC for Giapreza (angiotensin ii), Angiotensin ii 2.5 mg/mL injection, listed with the FDA by La Jolla Pharmaceutical Company. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Giapreza (Angiotensin II).
- What is the active ingredient?
- Angiotensin ii.
- Who is the labeler?
- La Jolla Pharmaceutical Company, NDC labeler code 68547. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Giapreza?
- 1 other product NDC are listed under this name. See all Giapreza NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Giapreza products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Giaprezaangiotensin ii | Angiotensin ii .5 mg/mL | InjectionIntravenous | La Jolla Pharmaceutical Company | 68547-005 | 68547-0005-01 |
Other NDCs under NDA 209360
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Giaprezaangiotensin ii | Angiotensin ii .5 mg/mL | InjectionIntravenous | La Jolla Pharmaceutical Company | 68547-005 |